Vaccines for the prevention of dengue: development update
- PMID: 21508679
- DOI: 10.4161/hv.7.6.14985
Vaccines for the prevention of dengue: development update
Abstract
The dengue viruses (DENV) are mosquito-borne flaviviruses which cause a spectrum of clinical disease known as "dengue," and have emerged and re-emerged as a significant global health problem. It is estimated more than 120 countries currently have endemic DENV transmission, 55% of the world's population is at risk of infection, and there are between 70-500 million infections of which 2.1 million are clinically severe resulting in 21,000 deaths annually. By all estimates the global dengue problem will continue to worsen due to the increasing mobility of the population, ecological changes, and the inability to effectively sustain vector control. There are no licensed antivirals or vaccines to treat or prevent dengue. The development and widespread use of a safe and efficacious dengue vaccine is required to significantly reduce the global dengue burden. In this review the authors discuss dengue vaccines currently in the pre-clinical and clinical development pipeline.
Similar articles
-
Critical issues in dengue vaccine development.Curr Opin Infect Dis. 2011 Oct;24(5):442-50. doi: 10.1097/QCO.0b013e32834a1b0b. Curr Opin Infect Dis. 2011. PMID: 21799408 Review.
-
Vaccines licensed and in clinical trials for the prevention of dengue.Hum Vaccin Immunother. 2017 May 4;13(5):1059-1072. doi: 10.1080/21645515.2016.1261770. Epub 2017 Feb 14. Hum Vaccin Immunother. 2017. PMID: 28281864 Free PMC article. Review.
-
Next-generation dengue vaccines: novel strategies currently under development.Viruses. 2011 Oct;3(10):1800-14. doi: 10.3390/v3101800. Epub 2011 Sep 26. Viruses. 2011. PMID: 22069516 Free PMC article.
-
Live attenuated vaccine: the first clinically approved dengue vaccine?Expert Rev Vaccines. 2014 Feb;13(2):185-8. doi: 10.1586/14760584.2014.870888. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350687
-
Current issues in dengue vaccination.Curr Opin Infect Dis. 2013 Oct;26(5):429-34. doi: 10.1097/01.qco.0000433310.28771.cc. Curr Opin Infect Dis. 2013. PMID: 23963259 Review.
Cited by
-
Dengue risk assessment using multicriteria decision analysis: A case study of Bhutan.PLoS Negl Trop Dis. 2021 Feb 10;15(2):e0009021. doi: 10.1371/journal.pntd.0009021. eCollection 2021 Feb. PLoS Negl Trop Dis. 2021. PMID: 33566797 Free PMC article.
-
Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.Am J Trop Med Hyg. 2013 May;88(5):962-970. doi: 10.4269/ajtmh.12-0461. Epub 2013 Mar 4. Am J Trop Med Hyg. 2013. PMID: 23458954 Free PMC article.
-
Laboratory-confirmed Dengue in Children in Three Regional Hospitals in the Philippines in 2009-2010.Pediatr Infect Dis J. 2015 Nov;34(11):1145-51. doi: 10.1097/INF.0000000000000810. Pediatr Infect Dis J. 2015. PMID: 26181893 Free PMC article.
-
Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development.Viruses. 2020 Nov 5;12(11):1261. doi: 10.3390/v12111261. Viruses. 2020. PMID: 33167518 Free PMC article. Review.
-
The Four Horsemen of the Apocalypse: Tropical Medicine in the Fight against Plague, Death, Famine, and War.Am J Trop Med Hyg. 2012 Jul;87(1):3-10. doi: 10.4269/ajtmh.2012.11-0814. Am J Trop Med Hyg. 2012. PMID: 22764283 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical